EQT completes sale of shares in Galderma Group AG

• The sale resulted in aggregate gross proceeds of c. CHF 1.86 billion, of which EQT received c. CHF 494 million

STOCKHOLM, June 3, 2025 /PRNewswire/ — Further to previous announcements, an affiliate of the funds known as EQT VIII (“EQT“) is pleased to announce the completion of the placement of 19,031,811 shares in Galderma Group AG (SIX: GALD) (the “Company“) (the “Shares“) for aggregate gross proceeds of c. CHF 1.86 billion via an accelerated bookbuilding process (the “Placement“). 

As part of the Placement, EQT received gross proceeds of c. CHF 494 million. The Placement was completed on 2 June 2025. Goldman Sachs, Jefferies, Morgan Stanley, RBC and UBS acted as joint global coordinators and joint bookrunners for the Placement.

Contact

EQT Press Office, [email protected]

Important notice

This press release does not constitute (i) an offer to sell or a solicitation of an offer to buy any securities of Galderma Group AG or any of its affiliates and it does not constitute a prospectus within the meaning of the Swiss Financial Services Act or (ii) an offer of securities for sale in the United States or elsewhere. Securities may not be offered or sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration. There will be no public offering of any of the securities mentioned in this press release in the United States.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/eqt-completes-sale-of-shares-in-galderma-group-ag,c4158542

The following files are available for download:

SOURCE EQT